Cook A E
Mathematica Policy Research, Inc., Princeton, NJ 08543, USA.
Health Care Financ Rev. 1999 Spring;20(3):29-37.
As policymakers consider adding a prescription drug benefit to Medicare, cost containment will be an important issue. This article discusses strategies to hold down the prices paid for prescription drugs. Within the private sector these include the use of formularies, the emergence of pharmaceutical benefit management companies, and the expansion of mail order pharmacies. In the Federal Government, costs are contained by the Medicaid drug rebate and the Federal Supply Schedule (FSS) of prices. Since Medicare beneficiaries constitute a large share of the prescription drug market, getting access to FSS prices may not be feasible. A flat rebate is one alternative.
在政策制定者考虑为医疗保险增加处方药福利之际，成本控制将是一个重要问题。本文讨论控制处方药支付价格的策略。在私营部门，这些策略包括使用药品处方集、药品福利管理公司的出现以及邮购药房的扩张。在联邦政府层面，成本通过医疗补助药品回扣和联邦供应价格表（FSS）来控制。由于医疗保险受益人在处方药市场中占很大份额，获取联邦供应价格表价格可能不可行。统一回扣是一种选择。
